{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T19:04:13Z","timestamp":1770750253936,"version":"3.50.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"vor","delay-in-days":1318,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1111\/jth.14392","type":"journal-article","created":{"date-parts":[[2019,1,20]],"date-time":"2019-01-20T06:14:36Z","timestamp":1547964876000},"page":"635-644","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Clinical pharmacology, efficacy and safety study of a triple\u2010secured fibrinogen concentrate in adults and adolescent patients with congenital fibrinogen deficiency"],"prefix":"10.1016","volume":"17","author":[{"given":"Claudia","family":"Djambas Khayat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"El Khorassani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9rie","family":"Gay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malika","family":"Barthez\u2010Toullec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Lamazure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Bellon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9line","family":"Henriet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7oise","family":"Bridey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claude","family":"N\u00e9grier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/jth.14392_bb0010","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1182\/blood-2004-02-0595","article-title":"Recessively inherited coagulation disorders","volume":"104","author":"Mannucci","year":"2004","journal-title":"Blood"},{"key":"10.1111\/jth.14392_bb0015","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1055\/s-0029-1225758","article-title":"Neerman\u2010Arbez. Congenital fibrinogen disorders","volume":"35","author":"De Moerloose","year":"2009","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/jth.14392_bb0020","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1365-2516.2004.00944.x","article-title":"The rare coagulation disorders \u2010 review with guidelines for management from the United Kingdom Haemophilia Centre Doctors\u2019 Organisation","volume":"10","author":"Bolton\u2010Maggs","year":"2004","journal-title":"Haemophilia"},{"key":"10.1111\/jth.14392_bb0025","first-page":"158","article-title":"Management of the hereditary coagulation disorders","volume":"8","author":"Mason","year":"1971","journal-title":"Semin Hematol"},{"key":"10.1111\/jth.14392_bb0030","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1161\/01.STR.30.11.2479","article-title":"Recurrent spontaneous intracerebral hemorrhage in a congenitally afibrinogenemic patient: diagnostic pitfalls and therapeutic options","volume":"30","author":"Henselmans","year":"1999","journal-title":"Stroke"},{"key":"10.1111\/jth.14392_bb0035","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1046\/j.1365-2516.2000.00448.x","article-title":"Spontaneous intracranial bleeding in two patients with congenital afibrinogenaemia and the role of replacement therapy","volume":"6","author":"Parameswaran","year":"2000","journal-title":"Haemophilia"},{"key":"10.1111\/jth.14392_bb0040","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/ajh.2830460416","article-title":"Congenital afibrinogenemia","volume":"46","author":"Al\u2010Mondhiry","year":"1994","journal-title":"Am J Hematol"},{"key":"10.1111\/jth.14392_bb0045","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/hae.12143","article-title":"Molecular basis of quantitative fibrinogen disorders in 27 patients from India","volume":"19","author":"Sumitha","year":"2013","journal-title":"Haemophilia"},{"key":"10.1111\/jth.14392_bb0050","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1056\/NEJMra067742","article-title":"Prevention and treatment of major blood loss","volume":"356","author":"Mannucci","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.14392_bb0055","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1186\/1752-1947-5-582","article-title":"Acute myocardial infarction in a patient with hypofibrinogenemia: a case report","volume":"5","author":"Mghaieth","year":"2011","journal-title":"J Med Case Rep"},{"key":"10.1111\/jth.14392_bb0060","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1046\/j.1365-2141.1999.01681.x","article-title":"Bleeding and thrombosis in 55 patients with inherited afibrinogenaemia","volume":"107","author":"Lak","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.14392_bb0065","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1111\/j.1538-7836.2006.02014.x","article-title":"Incidence of bleeding symptoms in 100 patients with inherited afibrinogenaemia or hypofibrinogenaemia","volume":"4","author":"Peyvandi","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14392_bb0070","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1111\/j.1538-7836.2011.04424.x","article-title":"Fibrinogen replacement therapy for congenital fibrinogen deficiency","volume":"9","author":"Bornikova","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"Suppl. 2","key":"10.1111\/jth.14392_bb0075","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/S0049-3848(13)70004-5","article-title":"Epidemiology and treatment of congenital fibrinogen deficiency","volume":"130","author":"Peyvandi","year":"2012","journal-title":"Thromb Res"},{"key":"10.1111\/jth.14392_bb0080","first-page":"229","article-title":"Immediate transfusion reactions","volume":"20","author":"Climent\u2010Peris","year":"2001","journal-title":"P R Health Sci J"},{"key":"10.1111\/jth.14392_bb0085","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/hae.12440","article-title":"Kreuth III: European consensus proposals for treatment of haemophilia with coagulation factor concentrates","volume":"20","author":"Giangrande","year":"2014","journal-title":"Haemophilia"},{"key":"10.1111\/jth.14392_bb0090","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1517\/21678707.2016.1108188","article-title":"Factor concentrates for rare congenital coagulation disorders: where are we now?","volume":"4","author":"de Moerloose","year":"2016","journal-title":"Expert Opin Orphan Drugs"},{"key":"10.1111\/jth.14392_bb0095","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/j.1538-7836.2008.03076.x","article-title":"Pharmacokinetics and pharmacodynamics of a new highly secured fibrinogen concentrate","volume":"6","author":"N\u00e9grier","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14392_bb0100","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1046\/j.1365-2141.2003.04256.x","article-title":"Guidelines on fibrinogen assays","volume":"121","author":"Mackie","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.14392_bb0105","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1111\/j.1538-7836.2009.03633.x","article-title":"Pharmacokinetics and safety of fibrinogen concentrate","volume":"7","author":"Manco\u2010Johnson","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14392_bb0110","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/jth.13923","article-title":"Pharmacokinetics, clot strength and safety of a new fibrinogen concentrate: randomized comparison with active control in congenital fibrinogen deficiency","volume":"16","author":"Ross","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14392_bb0115","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.transci.2004.08.003","article-title":"Efficacy and tolerability of a pasteurised human fibrinogen concentrate in patients with congenital fibrinogen deficiency","volume":"32","author":"Kreuz","year":"2005","journal-title":"Transfus Apher Sci"},{"key":"10.1111\/jth.14392_bb0120","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1517\/14712590903193051","article-title":"Fibrinogen concentrate \u2010 a potential universal haemostatic agent","volume":"9","author":"Fenger\u2010Eriksen","year":"2009","journal-title":"Expert Opin Biol Ther"},{"key":"10.1111\/jth.14392_bb0125","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/MBC.0b013e32830ef90c","article-title":"Rotational thromboelastography for monitoring of fibrinogen concentrate therapy in fibrinogen deficiency","volume":"19","author":"Kalina","year":"2008","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/jth.14392_bb0130","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/j.1365-2516.2008.01831.x","article-title":"Rare inherited disorders of fibrinogen","volume":"14","author":"Acharya","year":"2008","journal-title":"Haemophilia"},{"key":"10.1111\/jth.14392_bb0135","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/trf.14421","article-title":"Efficacy and safety of a new human fibrinogen concentrate in patients with congenital fibrinogen deficiency: an interim analysis of a Phase III trial","volume":"58","author":"Lissitchkov","year":"2018","journal-title":"Transfusion"},{"key":"10.1111\/jth.14392_bb0140","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1160\/TH14-06-0514","article-title":"Safety of fibrinogen concentrate: analysis of more than 27\u00a0years of pharmacovigilance data","volume":"113","author":"Solomon","year":"2015","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.14392_bb0145","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000452864","article-title":"Thrombosis in inherited fibrinogen disorders","volume":"44","author":"Korte","year":"2017","journal-title":"Transfus Med Hemother"},{"key":"10.1111\/jth.14392_bb0150","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0049-3848(01)00247-X","article-title":"Embolized ischemic lesions of toes in an afibrinogenemic patient: possible relevance to in\u00a0vivo circulating thrombin","volume":"102","author":"Dupuy","year":"2001","journal-title":"Thromb Res"},{"key":"10.1111\/jth.14392_bb0155","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1055\/s-0037-1613536","article-title":"Inhibition of thrombin generation in plasma by fibrin formation","volume":"89","author":"Mosesson","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.14392_bb0160","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1055\/s-0037-1613195","article-title":"Inhibition of thrombin generation in plasma by fibrin formation (Antithrombin I)","volume":"88","author":"de Bosch","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.14392_bb0165","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/BF00252836","article-title":"Increased prothrombin activation in a patient with congenital afibrinogenemia is reversible by fibrinogen substitution","volume":"72","author":"Korte","year":"1994","journal-title":"Clin Investig"},{"key":"10.1111\/jth.14392_bb0170","unstructured":"Guideline on the investigation of bioequivalence, Jan 2010; European Medicines Agency, CPMP\/EWP\/QWP\/1401\/98 Rev.1\/Corr**."}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.14392","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.14392","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jth.14392","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622029683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622029683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.14392","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:23:38Z","timestamp":1761535418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622029683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S1538783622029683"],"URL":"https:\/\/doi.org\/10.1111\/jth.14392","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical pharmacology, efficacy and safety study of a triple\u2010secured fibrinogen concentrate in adults and adolescent patients with congenital fibrinogen deficiency","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.14392","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}